Upregulation of MCT1/4 has been found in tumor cells of several tumors, including breast, lung, kidney, and melanoma [26,27], and may be associated with the regulation of hypoxia, the P53 and MYC genes, ERK-MAPK/AMPK signaling pathway, and so on. This evidence concerns the gene SLC16A1 and neoplasm.